Los puntos clave no están disponibles para este artículo en este momento.
Dexamethasone intravitreal implant may be an effective and safe alternative in treatment of chronic DME nonresponsive to regular IVB. However, its therapeutic efficacy decreases between the third and sixth months following the injection.
Totan et al. (Thu,) studied this question.